Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Laboratory and Clinical Medicine|October 22, 2002
Seasonal variation of endothelin-1, angiotensin II, and plasma catecholamines and their relation to outside temperatureHans-J Kruse, Iwona Wieczorek, Hartmut Hecker, et al.
BMC Research Notes|July 6, 2014
Prevalence of deep vein thrombosis in acutely admitted ambulatory non-surgical intensive care unit patientsHolger Lawall, Ralph Oberacker, Claudia Zemmrich, et al.
Clinical Drug Investigation|December 8, 2017
Comparison of Once-Daily Bemiparin with Twice-Daily Enoxaparin for Acute Deep Vein Thrombosis: A Multicenter, Open-Label, Randomized Controlled TrialIgor A Suchkov, Javier Martinez-Gonzalez, Sebastian M Schellong, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 16, 2012
Benefits and risks of preventing thromboembolism with enoxaparin in patients with general surgery in real world--the CLEVER studySebastian M Schellong, Albrecht Encke, Artur-Aaron Weber, et al.
Expert Opinion on Pharmacotherapy|October 19, 2010
An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAINSebastian M Schellong, Sylvia Haas, Andreas Greinacher, et al.
American Heart Journal|February 15, 2011
Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure: a subgroup analysis of the randomized, controlled CERTIFY studyUlrich Tebbe, Sebastian M Schellong, Sylvia Haas, et al.
Thrombosis and Haemostasis|December 8, 2009
Diagnosis of deep-vein thrombosis: adherence to guidelines and outcomes in real-world health careSebastian M Schellong, Horst Gerlach, Viola Hach-Wunderle, et al.
Thrombosis and Haemostasis|February 8, 2003
Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosisSebastian M Schellong, Thomas Schwarz, Kai Halbritter, et al.
The Lancet. Haematology|February 22, 2017
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trialJan Beyer-Westendorf, Sebastian M Schellong, Horst Gerlach, et al.
Thrombosis and Haemostasis|February 23, 2010
Impact of gender on the clinical presentation and diagnosis of deep-vein thrombosisRupert M Bauersachs, Hanno Riess, Viola Hach-Wunderle, et al.
Pageof 4